Subtopic Deep Dive
Oral Manifestations of COVID-19
Research Guide
What is Oral Manifestations of COVID-19?
Oral manifestations of COVID-19 refer to mucosal lesions including ulcers, vesicles, glossitis, and enanthema observed in infected patients, linked to high ACE2 receptor expression in oral epithelial cells.
Prospective studies document prevalence of these lesions in COVID-19 cohorts, with systematic reviews synthesizing evidence from multiple reports. Key papers include Xu et al. (2020) with 2908 citations on ACE2 expression and dos Santos et al. (2020) living review with 313 citations on lesion prevalence. Research debates direct viral causation versus secondary effects from immune dysregulation or treatments.
Why It Matters
Oral lesions serve as non-invasive diagnostic markers in atypical COVID-19 cases, aiding early detection where respiratory symptoms are absent (Huang et al., 2021, Nature Medicine, 790 citations). They inform prognostic assessments, with persistent shedding linked to mucosal involvement (Liu et al., 2020, Journal of Infection, 300 citations). In vaccination contexts, similar reactions highlight monitoring needs (McMahon et al., 2021, Journal of the American Academy of Dermatology, 803 citations), impacting dental and dermatological protocols globally.
Key Research Challenges
Distinguishing direct viral effects
Oral lesions may result from SARS-CoV-2 infection via ACE2 or from secondary factors like stress, medications, or immunosuppression (dos Santos et al., 2020, International Journal of Infectious Diseases, 353 citations). Histopathology and viral detection in saliva are needed to clarify (Huang et al., 2021, Nature Medicine, 790 citations).
Quantifying prevalence accurately
Heterogeneity in reporting across cohorts complicates meta-analysis, with living reviews showing variable lesion rates (dos Santos et al., 2020, Journal of Dental Research, 313 citations). Prospective studies are limited by pandemic constraints.
Linking to immune mechanisms
Cytokine involvement like IL-18 suggests autoinflammatory parallels, but specific pathways in oral mucosa remain unclear (Kaplanski, 2017, Immunological Reviews, 572 citations). Integration with systemic manifestations requires multi-organ studies (Ramos-Casals et al., 2021, Nature Reviews Rheumatology, 307 citations).
Essential Papers
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Hao Xu, Liang Zhong, J. S. Deng et al. · 2020 · International Journal of Oral Science · 2.9K citations
Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of 414 cases
Devon E. McMahon, Erin Amerson, Misha Rosenbach et al. · 2021 · Journal of the American Academy of Dermatology · 803 citations
SARS-CoV-2 infection of the oral cavity and saliva
Ni Huang, Paola Pérez, Takafumi Kato et al. · 2021 · Nature Medicine · 790 citations
Despite signs of infection-including taste loss, dry mouth and mucosal lesions such as ulcerations, enanthema and macules-the involvement of the oral cavity in coronavirus disease 2019 (COVID-19) i...
Interleukin‐18: Biological properties and role in disease pathogenesis
Gilles Kaplanski · 2017 · Immunological Reviews · 572 citations
Summary Initially described as an interferon ( IFN )γ‐inducing factor, interleukin (IL)‐18 is indeed involved in Th1 and NK cell activation, but also in Th2, IL ‐17‐producing γδ T cells and macroph...
The spectrum of COVID-19–associated dermatologic manifestations: An international registry of 716 patients from 31 countries
Esther E. Freeman, Devon E. McMahon, Jules B. Lipoff et al. · 2020 · Journal of the American Academy of Dermatology · 392 citations
Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations?
Juliana Amorim dos Santos, Ana Gabriela Costa Normando, Rainier Luiz Carvalho da Silva et al. · 2020 · International Journal of Infectious Diseases · 353 citations
Some oral manifestations have been observed in patients with coronavirus disease 2019 (COVID-19). However, there is still a question about whether these lesions are due to coronavirus infection or ...
Oral Manifestations in Patients with COVID-19: A Living Systematic Review
Juliana Amorim dos Santos, Ana Gabriela Costa Normando, R.L. Carvalho da Silva et al. · 2020 · Journal of Dental Research · 313 citations
This living systematic review aims to summarize evidence on the prevalence of oral signs and symptoms in patients with COVID-19. The review was reported per the PRISMA checklist, and the literature...
Reading Guide
Foundational Papers
Start with Xu et al. (2020) for ACE2 mechanism (2908 citations), then dos Santos et al. (2020) living review (313 citations) to grasp prevalence patterns before Huang et al. (2021) on saliva evidence.
Recent Advances
Study McMahon et al. (2021, 803 citations) on vaccine-related lesions and Ramos-Casals et al. (2021, 307 citations) for immune-systemic links post-2020.
Core Methods
Core techniques: cohort prevalence (dos Santos 2020), viral RNA in saliva (Huang 2021), ACE2 IHC (Xu 2020), systematic PRISMA reviews.
How PapersFlow Helps You Research Oral Manifestations of COVID-19
Discover & Search
Research Agent uses searchPapers with query 'oral manifestations COVID-19 ACE2' to retrieve Xu et al. (2020, 2908 citations), then citationGraph reveals 1000+ citing works on mucosal entry, and findSimilarPapers uncovers dos Santos et al. (2020) living review for prevalence data.
Analyze & Verify
Analysis Agent applies readPaperContent on Huang et al. (2021) to extract saliva viral loads, verifyResponse with CoVe cross-checks lesion causation against 10 similar papers, and runPythonAnalysis computes prevalence meta-stats from extracted tables using pandas, with GRADE grading for evidence quality in cohort designs.
Synthesize & Write
Synthesis Agent detects gaps like IL-18 role in oral persistence via contradiction flagging across Kaplanski (2017) and Ramos-Casals (2021), while Writing Agent uses latexEditText for manuscript sections, latexSyncCitations for 20+ refs, and latexCompile to generate a review PDF with exportMermaid timelines of lesion progression.
Use Cases
"Extract prevalence rates of oral ulcers in COVID-19 from systematic reviews and run meta-analysis."
Research Agent → searchPapers → Analysis Agent → readPaperContent (dos Santos 2020) → runPythonAnalysis (pandas meta-analysis forest plot) → outputs CSV of pooled OR=2.1 (95% CI 1.5-3.0).
"Write a LaTeX review on ACE2 expression and oral lesions with citations."
Synthesis Agent → gap detection → Writing Agent → latexEditText (intro) → latexSyncCitations (Xu 2020 et al.) → latexCompile → outputs compiled PDF with 15 figures.
"Find code for analyzing COVID-19 oral lesion images from papers."
Research Agent → paperExtractUrls (Huang 2021) → paperFindGithubRepo → githubRepoInspect → outputs Python scripts for vesicle segmentation with 80% accuracy on mucosal datasets.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (50+ oral COVID papers) → citationGraph clustering → GRADE synthesis → structured report on lesion typology. DeepScan applies 7-step verification: readPaperContent (dos Santos 2020) → CoVe on prevalence claims → runPythonAnalysis stats → checkpoint report. Theorizer generates hypotheses linking IL-18 upregulation (Kaplanski 2017) to glossitis persistence.
Frequently Asked Questions
What defines oral manifestations of COVID-19?
Lesions include ulcers, vesicles, enanthema, and glossitis, tied to ACE2 in mucosa (Xu et al., 2020, 2908 citations; Huang et al., 2021, 790 citations).
What methods study these manifestations?
Prospective cohorts, saliva PCR, histopathology, and living systematic reviews synthesize prevalence (dos Santos et al., 2020, Journal of Dental Research, 313 citations).
What are key papers?
Xu et al. (2020, Int J Oral Sci, 2908 cit.) on ACE2; dos Santos et al. (2020, Int J Infect Dis, 353 cit.) on lesion case; Huang et al. (2021, Nat Med, 790 cit.) on oral infection.
What open problems exist?
Causation (direct vs. secondary), prognostic value, and immune links like IL-18 need longitudinal studies (Kaplanski, 2017; Ramos-Casals et al., 2021).
Research Dermatological and COVID-19 studies with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Oral Manifestations of COVID-19 with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers